1. Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999. 44:989–990.
Article
2. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997. 337:956–962.
Article
3. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Eng J Med. 1997. 337:949–955.
Article
4. Dubey A, Recht A, Come SE, Gelman RS, Silver A, Harris JR, et al. Concurrent CMF and radiation therapy for early stage breast cancer: results od a pilot study. Int J Radiat Oncol Biol Phys. 1999. 45:877–884.
Article
5. Fiets WE, van Helvoirt RP, Nortier J, van der Tweel I, Struikmanse H. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: a prospective, comparative, non-randomised study. Eur J Cancer. 2003. 39:1081–1088.
Article
6. Choi HJ, Kwak KH, Kim JR, Sohn SC, Park KM, Han SH. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer. J Korean Breast Cancer Soc. 2004. 7:289–292.
Article
7. Han SH, Suh HS, Kim SR, Kim HY. Preliminary result of concurrent chemotherapy and radiotherapy in stage I and II breast cancer patients treated with breast conservation surgery. J Korean Breast Cancer Soc. 1998. 1:251–256.
Article
8. Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, et al. A prospective study of concurrent cyclophosphamide/methotrexate/ 5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer. 2004. 100:1358–1364.
Article
9. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996. 334:1356–1361.
Article
10. Recht A, Come SE, Gelman RS, Goldstein M, Tishler S, Gore M, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol. 1991. 9:1662–1667.
Article
11. Lamb D, Atkinson C, Joseph D, O'Brien P, Ackland S, Bonaventura A, et al. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australas Radiol. 1999. 43:220–226.
Article
12. Banerjee T, Hoehn J, Greenlaw R, Jacoby C. Chemotherapy drug dose alteration due to radiation therapy in an adjuvant situation in breast cancer. Am J Clin Oncol. 1984. 7:437–442.
Article
13. Habibollahi F, Fentiman IS, Chaudary MA, Winter PJ. Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat. 1989. 13:237–241.
Article
14. Pronzato P, Campora E, Amoroso D, Bertilli G, Botto F. Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer. Am J Clin Oncol. 1989. 12:481–485.
Article
15. Tada K, Ito Y, Takahashi S, Iijima K, Miyagi Y, Nishimura S, Takahashi K, et al. Tolerability and safety of classic cyclophosphamide, methotrexate, and fluorouracil treatment in japanese patients with early breast cancer. Breast Cancer. 2006. 13:279–283.
Article
16. Kimsey F, Mendenhall N, Ewald L, Coons TS, Layon AJ. Is radiation treatment volume a predictor for acute or late effect on pulmonary function? a prospective study of patients treated with breast-conserving surgery and postoperative irradiation. Cancer. 1994. 73:2549–2555.
Article
17. Taghian A, Assaad S, Niemierko A, Kuter I, Younger J, Schoenthaler R, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst. 2001. 93:1806–1811.
Article
18. Nam SJ, Noh DY, Yang JH, Choe KJ, Ha SW, Huh SJ. . Local treatment of invasive breast cancer. The Breast. 2005. 2nd ed. Korea: Ilchokak.
19. Lingos T, Recht A, Vicini F, Abner A, Silver B, Harris J. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991. 21:355–360.
Article
20. Abner AL, Recht A, Vicini FA, Silver B, Hayes D, Come S, et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1991. 21:331–338.
Article
21. Isaac N, Panzarella T, Lau A, Mayers C, Kirkbride P, Tannock I, et al. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Cancer. 2002. 95:696–703.
Article
22. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000. 355:949–955.
Article
23. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000. 18:1606–1613.
Article